Scientists are reprogramming how T cells work so they can fight against tumors, "turning them from cancer protectors into ...

The SCG2 hormone allows tumors to suppress immune defenses, opening up a new therapeutic avenue against cancer.

New research by the IU School of Medicine is looking at new ways to fight aggressive cancers. Right now the focus is on ...

Researchers in Georgetown University School of Medicine (SOM) professor Alejandro Villagra’s lab are continuing novel ...

Philadelphia’s pioneering cancer scientist, Carl June, has been honored with two awards in the last month for his seminal work engineering the body’s immune system to fight cancer. June has spent ...

The research describes a novel and unusual mechanism for T cells to remember the pathogens and cancers that they had ...

Researchers have published the first description of the role of the ZFP36 family of RNA binding proteins in regulatory T cells (Tregs). Tregs are key to maintaining balance in the immune system and ...

In almost all solid tumors—i.e. cancers with a solid tissue structure—the detection of tumor cells in the lymph nodes is ...

The immune system works to maintain homeostasis throughout the body. Various cell types and immune mechanisms work in concert to fight disease. Specifically, two waves of immunity orchestrate a robust ...

In the march of metastasis, a molecular trail of crumbs guides some cancer cells from the primary tumor to establish new ...

Scientists at the Sanford Stem Cell Institute at UC San Diego are in the midst of their ninth research mission, with samples ...

When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered patients immense hope. The long-awaited drug is a monoclonal antibody that ...